ursodeoxycholic acid has been researched along with Bile Duct Cancer in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (19.35) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Karlsen, TH; Vesterhus, M | 1 |
| Ferenci, P; Halilbasic, E; Stättermayer, AF; Trauner, M; Wrba, F | 1 |
| Hong, EM; Jang, HJ; Jung, JH; Kim, JH; Koh, DH; Lee, J; Park, SW | 1 |
| Beuers, U; Herta, T | 1 |
| Bancel, B; Brunel, T; Goubault, P; Mabrut, JY; Mohkam, K; Rode, A | 1 |
| Eaton, JE; Gores, GJ; Lazaridis, KN; Lindor, KD; Talwalkar, JA | 1 |
| Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM | 1 |
| Boberg, KM; Karlsen, TH; Vesterhus, M | 1 |
| Banales, JM; Briz, O; Hernández-Hernández, A; Lozano, E; Macias, RI; Marin, JJ; Monte, MJ | 1 |
| Geier, A; Tischendorf, JJ; Trautwein, C | 1 |
| Lindor, KD; Silveira, MG | 1 |
| Fickert, P; Halilbasic, E; Moustafa, T; Trauner, M | 1 |
| Cullen, S; Maggs, J | 1 |
| Chazouillères, O; Chrétien, Y; Corphechot, C; Garioud, A; Poupon, R; Poupon, RE; Seksik, P | 1 |
| Gotthardt, D; Kloeters-Plachky, P; Kulaksiz, H; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Boberg, KM; Karlsen, TH; Schrumpf, E | 1 |
| Ponsioen, CY | 1 |
| Blendis, L; Lurie, Y | 1 |
| Stiehl, A | 1 |
| Petersen-Benz, C; Stiehl, A | 1 |
| Gatzen, M; Pausch, J | 1 |
| Charatcharoenwitthaya, P; Lindor, KD | 1 |
| Kloeters-Plachky, P; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Fitz, JG; McGill, JM; Schlenker, T; Shimokura, GH | 1 |
| Finnie, I; Gilmore, I; Lombard, MJ; Rhodes, JM; Sutton, R | 1 |
| Ghosh, S; Palmer, KR | 1 |
| Crepaldi, G; Knuth, A; Poci, C; Sartori, L; Spirlí, C; Strazzabosco, M | 1 |
| Benz, C; Sauer, P; Stiehl, A | 1 |
| Franco, J; Saeian, K | 1 |
| Fleig, WE; Halm, U; Keim, V; Mössner, J | 1 |
| Grüne, S; Moradpour, D; Müllhaupt, B; Münch, R; Siegenthaler, W; Siegenthaler-Zuber, G | 1 |
16 review(s) available for ursodeoxycholic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities.
Topics: Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Liver Transplantation; Research Design; Severity of Illness Index; Ursodeoxycholic Acid | 2020 |
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Bile Duct Neoplasms; Chemical and Drug Induced Liver Injury; Cholelithiasis; Cholestasis, Intrahepatic; Female; Gallbladder Neoplasms; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2020 |
[Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges].
Topics: Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2019 |
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B; Bile; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis; Cholangitis, Sclerosing; Cholecystectomy; Cholelithiasis; Codon, Nonsense; Diagnosis, Differential; Female; Gallstones; Humans; Lithiasis; Liver Abscess; Liver Cirrhosis, Biliary; Liver Diseases; Mutation; Phosphatidylcholines; Pregnancy; Pregnancy Complications; Recurrence; Syndrome; Ultrasonography; Ursodeoxycholic Acid | 2019 |
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Colonic Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Gallbladder Neoplasms; Genetic Predisposition to Disease; Humans; Immunity, Innate; Immunosuppressive Agents; Intestines; Liver Transplantation; Metagenome; Ursodeoxycholic Acid | 2013 |
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Humans; Immunosuppression Therapy; Liver Cirrhosis, Biliary; Liver Transplantation; Prognosis; Time Factors; Ursodeoxycholic Acid | 2014 |
Current diagnosis and management of primary sclerosing cholangitis.
Topics: Algorithms; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Endoscopy; Gastroenterology; Humans; Liver Transplantation; Prognosis; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2008 |
Primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangiography; Cholangitis, Sclerosing; Humans; Liver; Liver Transplantation; Prognosis; Recurrence; Ursodeoxycholic Acid | 2008 |
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile; Bile Acids and Salts; Bile Canaliculi; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholangiocarcinoma; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Cholic Acids; Disease Models, Animal; Humans; Liver Neoplasms; Mice; Mice, Knockout; Mutation; Norsteroids; Ursodeoxycholic Acid | 2008 |
Management of autoimmune liver disease.
Topics: Autoantibodies; Azathioprine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangiocarcinoma; Clinical Trials as Topic; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid | 2009 |
Primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiography; Cholangitis, Sclerosing; Comorbidity; Disease Progression; Gallbladder Neoplasms; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Inflammatory Bowel Diseases; Linkage Disequilibrium; Liver Cirrhosis; Liver Transplantation; Practice Guidelines as Topic; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2010 |
Recent insights in primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Transplantation; Ursodeoxycholic Acid | 2012 |
[Primary sclerosing cholangitis].
Topics: Bile Duct Neoplasms; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Comorbidity; Humans; Liver Function Tests; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2004 |
[Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?].
Topics: Adult; Age Factors; Bile Acids and Salts; Bile Duct Neoplasms; Cholangiocarcinoma; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Liver Cirrhosis, Biliary; Long-Term Care; Middle Aged; Pregnancy; Risk Factors; Ursodeoxycholic Acid | 2006 |
Primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colonic Neoplasms; Constriction, Pathologic; Humans; Liver Transplantation; Ursodeoxycholic Acid | 2000 |
Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Risk Factors; Ursodeoxycholic Acid | 1999 |
4 trial(s) available for ursodeoxycholic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Biomarkers, Tumor; CA-19-9 Antigen; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cohort Studies; Constriction, Pathologic; Dilatation; Humans; Longitudinal Studies; Risk Assessment; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Preventing biliary stent occlusion.
Topics: Bile Duct Neoplasms; Cholestasis; Humans; Stents; Ursodeoxycholic Acid | 1994 |
Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile Duct Neoplasms; Cholangiocarcinoma; Cholestasis, Extrahepatic; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Postoperative Complications; Stents; Treatment Outcome; Ursodeoxycholic Acid | 1994 |
Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial.
Topics: Aged; Anti-Infective Agents; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Drug Therapy, Combination; Female; Humans; Male; Ofloxacin; Postoperative Complications; Prospective Studies; Stents; Ursodeoxycholic Acid | 2001 |
11 other study(ies) available for ursodeoxycholic acid and Bile Duct Cancer
| Article | Year |
|---|---|
Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Deoxycholic Acid; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biological Transport; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Chlorophyllides; Cholangiocarcinoma; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Technology, Pharmaceutical; Ursodeoxycholic Acid | 2013 |
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cisplatin; Drug Delivery Systems; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Organoplatinum Compounds; Rats; Rats, Wistar; Symporters; Ursodeoxycholic Acid | 2015 |
Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangitis, Sclerosing; Cohort Studies; Colorectal Neoplasms; Female; France; Gallbladder Neoplasms; Humans; Incidence; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2010 |
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Cholangitis, Sclerosing; Cholestasis; Colorectal Neoplasms; Comorbidity; Female; Follow-Up Studies; Gallbladder Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Survival Rate; Ursodeoxycholic Acid; Young Adult | 2010 |
Primary sclerosing cholangitis: a premalignant condition.
Topics: Bile Duct Neoplasms; Cholangitis, Sclerosing; Humans; Liver Neoplasms; Pancreatic Neoplasms; Precancerous Conditions; Ursodeoxycholic Acid | 2002 |
Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Topics: Alkaline Phosphatase; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Biopsy; CA-19-9 Antigen; Carcinoembryonic Antigen; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Colitis, Ulcerative; Diagnostic Imaging; Disease Progression; Humans; Male; Middle Aged; Practice Guidelines as Topic; Ursodeoxycholic Acid | 2007 |
The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.
Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Child; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Female; Humans; Long-Term Care; Male; Middle Aged; Patient Dropouts; Prospective Studies; Ursodeoxycholic Acid | 2007 |
Ursodeoxycholate increases cytosolic calcium concentration and activates Cl- currents in a biliary cell line.
Topics: Bile Duct Neoplasms; Calcium; Cell Membrane Permeability; Chloride Channels; Cholangiocarcinoma; Cytosol; Humans; Membrane Potentials; Patch-Clamp Techniques; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1995 |
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line.
Topics: Acid-Base Equilibrium; Bicarbonates; Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Intrahepatic; Biological Transport; Cholangiocarcinoma; Diffusion; Epithelium; Humans; Hydrogen-Ion Concentration; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1994 |
[Primary sclerosing cholangitis].
Topics: Adenoma, Bile Duct; Adult; Bile Duct Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatic Duct, Common; Humans; Liver Transplantation; Male; Prognosis; Ursodeoxycholic Acid | 1991 |